SynthesisBreast (Edinburgh, Scotland)2022

Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer.

Nadia HarbeckPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.